Carol has more than 25 years of experience in investment banking, equity capital markets, corporate finance and business development in the healthcare sector. She currently serves on the Board of Directors for Insmed Incorporated (Nasdaq: INSM), Immunome, Inc. (Nasdaq: IMNM), Kura Oncology, Inc (Nasdaq: KURA) and Repare Therapeutics Inc. (Nasdaq: RPTX). In addition, Carol previously served on the Board of Directors of Five Prime Therapeutics, Inc. (acquired by Amgen for $1.9 billion in April 2021) and Idera Pharmaceuticals, Inc. (until its merger in September 2022).
From 2007 to 2018, Carol worked at Wells Fargo Securities in a variety of roles, including as Vice Chair, Equity Capital Markets. Prior to this, Carol worked at J.P. Morgan, where she held positions of increasing responsibility including Managing Director, Equity Capital Markets. She holds a Master of Business Administration from New York University’s Stern School of Business and a Bachelor of Arts from Boston College.
“I am honoured to join the Board and contribute to the OMass’s mission of developing first or best-in-class small molecules for areas of high unmet need in endocrinology and immunology,” commented Carol Schafer, non-executive Director and Chair of the Audit Committee at OMass Therapeutics. “I look forward to working with the Board to help guide the company as they advance towards the clinic and prepare for their next phase of growth.”
“Carol’s extensive combination of healthcare investment banking experience and biotech board experience will be invaluable to OMass as we move towards becoming a clinical-stage company,” added Jim Geraghty, Chairman of OMass Therapeutics’ Board of Directors. “I am confident that her strategic insight and understanding of equity markets will be a tremendous asset to the company. We are pleased to welcome her to the Board and as our new audit committee chair.”
-ENDS-
For further information, please contact:
| OMass Therapeutics | |
| Rosamond Deegan, Chief Executive Officer
Email: ros.deegan@omass.com |
|
|
ICR Healthcare (For media) |
|
| Namrata Taak / Ashley Tapp
Email: omass@icrhealthcare.com |